Our Recommendations
- Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19 (2021)
- Orientations sur l’élaboration d’un plan national de déploiement et de vaccination applicable aux vaccins contre la COVID-19 (2020)
- Immunization in the context of COVID-19 pandemic (2020)
- Institute for Health Metrics and Evaluation (2022)
- La vaccination dans le contexte de la pandémie de COVID-19 (2020)
New Publications
- Guidance on development and implementation of a national deployment and vaccination plan for vaccines against pandemic influenza and other respiratory viruses of pandemic potential (2023)
- The Big Catch-Up: An Essential Immunization Recovery Plan for 2023 and Beyond (2023)
- Modelling COVID-19 vaccination status and adherence to public health and social measures, Eastern Mediterranean Region and Algeria (2023)
- Meeting of the Strategic Advisory Group of Experts on Immunization, October 2022: conclusions and recommendations (2023)
- COVAX: Structure and Principles (2022)
Filter
482
Featured
Recommendations
71
Language
Document type
Fact sheets
129
Videos
87
Guidelines
60
Resource Platforms
57
Studies & Reports
47
Manuals
36
Infographics
21
Strategic & Response Plan
13
Training Material
9
Online Courses
8
Situation Updates
7
No document type
6
Brochures
1
App
1
Countries / Regions
Germany
38
Middle East and North Africa
20
Latin America and the Carribbean
18
Brazil
13
Ukraine
11
Russia
11
Africa
10
Syria
9
Yemen
9
West and Central Africa
8
East and Southern Africa
8
South Africa
6
South Sudan
5
China
4
Mozambique
4
Global
4
Congo, Democratic Republic of
4
United Kingdom
4
Sudan
4
Angola
4
Colombia
3
Guinea-Bissau
3
Lebanon
3
India
3
Philippines
2
Eastern Europe and Central Asia
2
Western and Central Europe
2
Argentina
2
Mali
2
Thailand
1
Kenya
1
Ghana
1
Sierra Leone
1
Kazakhstan
1
Nigeria
1
Canada
1
Senegal
1
Niger
1
Burkina Faso
1
Malawi
1
Morocco
1
USA
1
Saudi Arabia
1
South–East Asia Region
1
Gabon
1
Jamaica
1
Tunisia
1
South Korea
1
Belarus
1
French Guyana
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Bangladesh
1
Vietnam
1
Uganda
1
Nicaragua
1
Ethiopia
1
Indonesia
1
Somalia
1
Ecuador
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
126
Women & Child Health
19
Clinical Guidelines
9
Key Resources
8
Capacity Building
7
Pharmacy & Technologies
2
Public Health
1
Alle Fragen zu Impfmythen und Verschwörungstheorien
Zusammen gegen Corona.
Die Meldungen zu Impfstoffen gegen das Coronavirus und die COVID-19-Erkrankung stimmen optimistisch. Möglich ist, dass es noch 2020 erste Zulassungen in Europa geben kann. Hier erfahren Sie mehr zur Impfstoffentwicklung, Impfstofftypen und zur geplanten Organisation und Vert...
13 May 2021 The diagram supports health workers by outlining key steps and messages to communicate during a COVID-19 vaccination session.
15 January 2021
This Aide Memoire is for policy makers, immunization programme managers, infection prevention and control (IPC) focal points at national, sub-national, and facility level, as well as for health workers involved in COVID-19 vaccination delivery. This document summarizes the key IPC p...
conducted for the World Economic Forum
The Platform has functionality for country-level users, such as uploading theNational Deployment and Vaccination Planon the Info tab by the WCO vaccine expert, followed by validation by a government official. The Platform has functionality for regional users, such as Reviewingof National Deployment ...
COVID-19 Vaccination in the Americas
recommended
On March 1, 2021, the countries of the Americas began receiving vaccines through the COVAX Mechanism, an unprecedented global effort between CEPI, Gavi, Unicef, PAHO, and WHO to ensure equitable access to immunization throughout the world. The PAHO Revolving Fund is the mechanism designated by COVA...
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
Vaccines are supported by decades of medical research. ...
This article is part four in a series of explainers on vaccine development and distribution
Available in different languages
Diese Informationen sind zur Weitergabe an Patient:innen und Bürger:innen.
Lorsqu’un virus circule largement dans une population et entraîne de nombreuses infections, la probabilité de mutation augmente. Plus un virus a de possibilités de se propager, plus il se réplique – et plus il est susceptible de muter. L’arrêt de la propagation du virus à la source res...
YouTube influencer Healthcare Triage talked with WHO's Dr Kate O'Brien about how the COVID-19 vaccine works, how it gets distributed, and how we distribute it equitably.
1:27 Safety questions and concerns about quick development of the vaccine.
7:18 Have we entered a new age where all vaccines wi...
Empfehlungen f ür das politische Handeln des Bundes und der Länder so wie angeschlossene Behörden
Version 01, veröffentlichtam 16.12.2020
Vaccines explained
recommended
WHO's 'Vaccine Explained' series features illustrated articles on vaccine development and distribution. Learn more about vaccines from the earliest of research stages to their rollout in countries.
Availble in different languages
31 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
Vaccines are a critical tool in the battl...
13 April 2021 Policy Brief
COVID-19 Vaccine Introduction Readiness Assessment Tool (VIRAT2), developed by WHO-PAHO, UNICEF, World Bank, Gavi, and other partners is a tool to help prepare countries for the introduction a COVID-19 vaccine.
It provides a roadmap for introduction and a structured framework for countries to self-...
This report provides an overview of the progress in the roll-out of COVID-19 vaccines in adults (aged 18 years and above) across EU/EEA Member States. It presents the number of vaccine doses distributed by manufacturers to each Member State for the different approved vaccines and the number of first...
